Randomised controlled trial of carbamazepine assisted detoxification in patients with benzodiazepine dependence

Not Applicable

Completed

• Conditions: Mental and Behavioural Disorders: Addiction; Mental and Behavioural Disorders; Addiction

• Registration Number: ISRCTN44535130
• Lead Sponsor: Department of Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-09-30
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients (18-65 years) who are admitted to Wentworth House or Kenyon House in-patient units, and are using daily doses of benzodiazepine for at least 3 months.

Exclusion Criteria

1. Significant psychiatric disorders (by ICD 10)
2. History of or current liver failure
3. Current Alanine Transaminase ( ALT) > or equal 150 IU/l in serum LFT
4. Current suicidal ideation
5. Patients who are already on Carbamazepine before referral for In Patient treatment.

Study & Design

• Study Type: Interventional
• Study Design: Not specified